MEDP: Medpace Holdings, Inc.
About
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.
Current Value
$340.171 Year Return
Current Value
$340.171 Year Return
Key Details
Market Cap
$10.64B
P/E Ratio
29.97
1Y Stock Return
22.48%
1Y Revenue Growth
16.24%
Dividend Yield
0.00%
Price to Book
12.0
Strategies that include MEDP
Stock's related to MEDP
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CRL | 56.45% | $10.29B | +0.32% | 0.00% |
| PCAR | 56.19% | $60.94B | +28.21% | 1.00% |
| IQV | 53.63% | $36.62B | -6.70% | 0.00% |
| BRKR | 46.64% | $8.85B | -12.05% | 0.34% |
| FI | 43.42% | $124.31B | +67.63% | 0.00% |
| FTRE | 42.36% | $1.95B | -31.26% | 0.00% |
| ICLR | 41.81% | $17.63B | -19.90% | 0.00% |
| LOGI | 40.95% | $12.15B | -5.49% | 1.69% |
| AOS | 40.86% | $10.89B | -3.17% | 1.74% |
| CR | 40.02% | $10.37B | +69.70% | 0.46% |
| FELE | 39.89% | $4.95B | +18.87% | 0.93% |
| RVMD | 38.34% | $8.71B | +113.78% | 0.00% |
| AZEK | 36.35% | $7.58B | +51.79% | 0.00% |
| MSA | 35.72% | $6.87B | -1.19% | 1.15% |
| AZZ | 35.59% | $2.86B | +85.30% | 0.71% |
| ASPN | 34.74% | $1.25B | +39.93% | 0.00% |
| ABG | 34.58% | $5.19B | +19.00% | 0.00% |
| SXI | 34.32% | $2.53B | +51.66% | 0.58% |
| APG | 34.09% | $6.52B | +23.85% | 0.00% |
| NEP | 34.08% | $1.84B | -18.75% | 18.28% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| LMT | -22.70% | $123.34B | +15.45% | 2.45% |
| PM | -16.83% | $203.71B | +40.99% | 3.98% |
| TBI | -14.19% | $235.88M | -47.15% | 0.00% |
| MSCI | -12.32% | $47.73B | +15.89% | 1.05% |
| MNR | -11.80% | $1.59B | -13.83% | 20.59% |
| HUSA | -9.66% | $17.54M | -25.14% | 0.00% |
| SSRM | -9.10% | $1.15B | -51.07% | 0.00% |
| IMMP | -9.05% | $298.19M | -0.49% | 0.00% |
| KREF | -8.66% | $816.58M | -9.78% | 10.05% |
| PRPO | -8.49% | $8.83M | -10.62% | 0.00% |
| PTMN | -8.37% | - | - | 16.45% |
| CCK | -8.35% | $11.06B | +4.44% | 1.08% |
| NEUE | -8.09% | $41.67M | -22.85% | 0.00% |
| LUMO | -7.61% | $37.88M | +41.29% | 0.00% |
| IRBT | -6.85% | $249.05M | -77.88% | 0.00% |
| TDC | -6.82% | $3.01B | -34.34% | 0.00% |
| EFSC | -6.57% | $2.22B | +45.52% | 1.71% |
| BCAN | -6.22% | $72.74M | -99.70% | 0.00% |
| CIG.C | -5.92% | $2.24B | +1.80% | 0.00% |
| VSTA | -5.78% | $194.41M | -41.46% | 0.00% |
ETF's related to MEDP
News
SeekingAlpha
Invesco Discovery Fund underperformed in the third quarter but maintains a lead versus the benchmark year to date. Read more here.
SeekingAlpha
Invesco Health Care Fund underperformed its benchmark. Despite earlier signs of improving trends, our health care outlook is bearish. Read more here.
Finnhub
RADNOR, Pa., Nov. 20, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of investors...
SeekingAlpha
Baird Small/Mid Cap Growth portfolio increased +6.9% in 3Q, net of fees, compared to the +7.0% increase in our primary benchmark, the Russell 2500 Growth Index.
Finnhub
NEW YORK, Nov. 10, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Medpace Holdings, Inc. . Such investors are advised to contact Danielle Peyton at...
Finnhub
RADNOR, Pa., Nov. 9, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of investors of...
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.